Kaiser Ozempic Prior Authorization (2026): What Your Region Checks and What to Do If It's Denied

Disclosure: Some links on this page are affiliate links, marked "sponsored." If you use one, we may earn a fee at no cost to you. That never changes what Kaiser's documents say. Kaiser does not pay us.

Kaiser Ozempic prior authorization depends on your region and exact plan. California's commercial HMO and Marketplace formularies say no plan-level PA is required. Other Kaiser plans use approval rules. Northwest's standard adult starting rule includes an A1c above 6.9% and below 10%. Weight-loss coverage is a separate question—not a promise from a diabetes approval. Sources: California formulary; Northwest criteria.

Here's the part that catches people off guard: in at least one Kaiser region, your A1c can be too high for the standard rule. We'll show you where that happens, and what to ask for instead.

Your answer changes if:

• You're on Kaiser Medicare. The published October 1, 2026 drug list shows PA for Ozempic. That does not establish that PA is new on October 1. Use Medicare criteria, not another region's commercial rules. Kaiser Medicare documents.
• You're on Medi-Cal. The state's Medi-Cal Rx program handles this pharmacy benefit, including its diagnosis and PA rules. Medi-Cal Rx.
• Your employer bought a weight-loss rider. In Kaiser Washington, Ozempic is the semaglutide used for that benefit, subject to approval rules. Kaiser Washington notice.

One more thing up front. We found no Ozempic approval odds in the Kaiser documents we checked, and we won't make one up. What Kaiser does publish includes rules your chart may have to meet. That's what this page walks you through.

This page is for you if:

• Your Kaiser doctor or pharmacy said Ozempic "needs approval" or "doesn't meet criteria"
• Kaiser denied it and you want to know why
• You just joined Kaiser and already take Ozempic
• You're on Kaiser Medicare and want to check whether an approval rule applies to you

Skip this page if:

• Kaiser already filled it and you want your price → Does Kaiser cover Ozempic?
• You want medicine for weight loss only → Go straight to the weight-loss section
• You don't have Kaiser → UnitedHealthcare, CVS Caremark, or Blue Cross Ozempic prior authorization

### Prepare my Kaiser Ozempic request → Find your plan's document, check what is missing, and use the message below to ask your care team for the next step. The checklist is on this page. You don't need to enter medical details here.

Start with what happened

What we actually verified (September 22, 2026)

• Kaiser Northwest's Ozempic injection rules (effective July 1, 2026), its separate Ozempic tablet rules (effective July 1, 2026), and two older versions still online (effective November 6, 2025 and June 4, 2026)
• Kaiser Northwest's drug coverage request form for prescribers
• Kaiser Mid-Atlantic's Semaglutide Products form for Commercial, Exchange and FEHB plans (effective August 4, 2026), plus its separate Maryland Medicaid form
• Kaiser Georgia's prior authorization criteria, including the diabetes and weight-management sections (effective September 9, 2026)
• Kaiser Washington's January 2026 provider notice on Ozempic
• Kaiser drug lists for Northern and Southern California, the California Marketplace, Colorado, Georgia, Hawaii and Washington
• Kaiser's 2026 Medicare coverage-decision and appeal instructions
• Medicare's GLP-1 Bridge drug list and Medi-Cal Rx's 2026 GLP-1 rules
• Novo Nordisk's Ozempic and Wegovy self-pay prices, Ro's published prices and terms, and Sesame's advertised program fees

What we could not verify: your personal coverage, approval odds, average wait times, or a complete Ozempic criteria set for Colorado, Washington and Hawaii from the documents we found. We didn't access any member account, submit a request, or test a provider checkout. The linked source documents appear beside the findings below.

The RX Index is the independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

---

Does Kaiser require prior authorization for Ozempic?

Kaiser requires prior authorization for Ozempic on some plans but not others. California's commercial HMO and Marketplace drug lists say no plan-level PA is required. Colorado, Georgia, Washington, the Mid-Atlantic and the Northwest publish approval requirements or written criteria. Medicare has its own process. California formulary; Kaiser Medicare.

Quick definitions, so the rest of this page reads easy:

• Prior authorization (PA) means your plan has to okay a medicine before it pays.
• A formulary is your plan's list of covered drugs. Being on the list doesn't mean you're approved.
• Step therapy means trying the plan's preferred drugs first, unless an allowed exception applies.

Here are the Kaiser Ozempic documents we compared, side by side. The useful difference is the plan, the exact rule, and the next step—not an approval score.

The Kaiser Ozempic Approval Rulebook (checked September 22, 2026)

Two warnings before you use the table. First, Kaiser updates these files. Northwest still has older Ozempic PDFs online, and Mid-Atlantic now links a newer product-specific form. Second, a region row is not your plan. Your Evidence of Coverage (EOC), which is your plan's contract, still decides which benefits and review process apply. Northwest directory; Mid-Atlantic directory.

At Kaiser, your chart matters—but the right request still matters too

Kaiser connects health coverage, medical care and pharmacy services. A group of Kaiser doctors and pharmacists—its Pharmacy and Therapeutics Committee—helps choose the drug list. But a request may still go through a separate review process, including OptumRx for the Kaiser Medicare process linked here. How Kaiser's formulary works; Medicare requests.

So one useful question is this: does your chart already prove you fit the rule your plan is using?

That changes your job. You're making sure your Kaiser chart shows the right facts before the request goes in, and that the request reaches the right team. Kaiser's own drug lists also say a drug being on the list doesn't mean every doctor will prescribe it for every reason. California formulary.

First, name the real problem

People say "prior authorization" for five different problems. Each one has a different fix.

This is a next-step guide, not a diagnosis of your denial. A letter cannot add a benefit the plan does not offer, but you can challenge a decision that applies the wrong rule. Knowing which row you're in helps you ask the right question. The rest of this page covers the approval process most. Kaiser exceptions; Medicare review rights.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose. The tool is a starting point for comparing treatment paths, not a Kaiser benefits check. Compounded medicines are not FDA-approved and are not Ozempic.

---

What does Kaiser check before it approves Ozempic?

The detailed non-Medicare diabetes rules check the diagnosis, medicine history and other requirements for your specific branch. Some also set an A1c range. Not every branch has an A1c cutoff or the same drug trials, and Medicare uses separate criteria. Northwest; Mid-Atlantic; California Medicare.

Use the table to prepare questions, not to decide which medicines to take. The exact requirements are in the regional sections below. Northwest criteria; Mid-Atlantic form.

The A1c window: why "too high" can stall you

A1c is a blood test that shows your average blood sugar over about three months. NIDDK.

Kaiser Northwest's standard adult new-start rule is not just "A1c above 7%." It says above 6.9% and below 10%, after an adequate trial of the required medicines. Northwest criteria.

That upper limit surprises people. If your last A1c was 10.4%, you don't fit Northwest's standard new-start lane. That isn't a forever no. Northwest has a separate new-start lane for people already taking at least 0.5 units of insulin per kilogram per day, and that lane has no upper A1c limit. Ask your doctor which lane fits you. Do not start or raise insulin to qualify for insurance. Northwest criteria.

Kaiser Mid-Atlantic's Commercial, Exchange and FEHB form wants an A1c from the last 3 months. If it is 2 or more percentage points above your goal, the form requires insulin therapy that has been adjusted to the best tolerated dose, with adherence documented, or the stated intolerance exception. For a 7% goal, 9% or higher triggers that insulin question. Current semaglutide form.

If you wear a glucose sensor, Kaiser Northwest also accepts GMI (Glucose Management Indicator, an estimate based on sensor glucose readings) where its criteria specify A1c or GMI. GMI and a lab A1c are not the same test. Northwest criteria.

The drugs Kaiser wants first, including the liraglutide step

Kaiser Northwest's standard adult new-start lane asks that you be currently taking at least 2 of these 4 for 3 months or more, at the doses specified in the rule:

1. Metformin
2. A sulfonylurea, such as glipizide
3. Pioglitazone
4. An SGLT2 drug, such as dapagliflozin or Jardiance

The list specifies maximum-tolerated metformin and sulfonylurea, plus pioglitazone and an SGLT2 drug. Taking fewer than two needs documented intolerance or a contraindication—a medical reason the remaining options should not be used. Northwest criteria.

Then comes another step: liraglutide. Liraglutide is an older, once-a-day shot in the same drug family as Ozempic. The brand is Victoza, and it now comes as a generic. Northwest's standard new-start lane also requires maximum-tolerated liraglutide, with 1.8 mg per day listed, or documented intolerance or a contraindication. Mid-Atlantic's current diabetes form also includes liraglutide. Georgia's review criteria describe generic liraglutide as preferred without PA. FDA generic approval; Northwest; Mid-Atlantic; Georgia.

If your branch includes liraglutide and you've never tried it, ask your doctor to check that step before submitting the request.

One safety line, and we mean it: don't take a medicine just to check a box. If a drug made you sick, tell your doctor and ask them to write down exactly what happened. The record needs to show the intolerance or contraindication the policy allows—not just a preference for Ozempic.

What counts as "I tried it"

Kaiser Northwest defines an adequate trial as 3 months. It also says mild expected side effects that resolve and do not require stopping treatment do not count as intolerance under that policy. Northwest criteria.

Kaiser Mid-Atlantic goes a step further. Its form checks medication adherence, using a refill-based measure called MRAR. The stated trial requires at least 80% adherence for 3 months or more, unless an allowed exception applies. That is not the same as counting how many pickups happened on time. Mid-Atlantic form.

Here's the practical check: ask your care team to compare the days supplied, dates and dose with what you actually took. One fill could cover 30 days or 90 days. The number of fills alone does not prove whether you completed the required trial.

What doesn't count as heart disease

Kaiser Northwest has a separate lane for people with type 2 diabetes plus certain heart or artery disease. It has different drug requirements, not an automatic approval. Kaiser's definition counts:

• a heart attack or acute coronary syndrome
• chest pain from blocked arteries (angina)
• a stent or bypass
• a stroke or TIA (a "mini-stroke") caused by clogged arteries
• leg-artery disease that causes symptoms

A high coronary calcium score, or being "high risk," does not count by itself in this Northwest branch. The listed stroke, TIA and artery conditions must meet the policy's atherosclerotic-disease definition. Northwest criteria.

The safety screen

Every Kaiser Northwest lane rules out a personal or family history of medullary thyroid cancer (MTC) or MEN 2 (a rare inherited condition). The FDA label contraindicates Ozempic in people with a personal or family history of MTC or in people with MEN 2. It's not paperwork to argue with. If it applies to you, talk with your clinician about other options. Northwest criteria; Ozempic prescribing information.

A prior serious allergic reaction to semaglutide or an ingredient is also a contraindication. Passing an insurance checklist is not a full safety assessment. Your clinician still needs to review your health history and medicines. Ozempic prescribing information.

---

What are the Kaiser Ozempic rules in my region?

Kaiser's Ozempic rules differ by region, plan and product. Northwest, Mid-Atlantic and Georgia publish detailed criteria. The Washington and Colorado documents we found list approval requirements but do not give a full clinical checklist. California's commercial HMO and Marketplace plans say no plan-level PA is required; Hawaii's listing alone does not settle the question. Regional sources in the rulebook.

Find your region below. Each one starts with the thing that matters most.

California (Northern, Southern, and Marketplace): no plan-level PA in these formularies

For the California commercial HMO and Marketplace formularies checked here, a missing PA form is not the default explanation.

These drug lists show Ozempic pens at Tier 2 and say the health plan does not require PA. That's good news. It does not mean your doctor must prescribe it, that a decision will happen at one visit, or that every use is covered. Northern California; Southern California; Marketplace.

If your doctor says no:

1. Ask for the reason in writing through kp.org.
2. Ask for a second opinion inside Kaiser.
3. If you still disagree, ask Member Services for the grievance process. Kaiser's formulary page describes this option when a requested drug is not considered medically necessary. Kaiser instructions.
4. For an eligible medical-necessity dispute under a DMHC-regulated plan, California's Department of Managed Health Care offers a free Independent Medical Review (IMR). Usually you use the plan's grievance process first; urgent cases can go to DMHC sooner. An IMR decision in your favor is binding. Not every benefit dispute qualifies for IMR. DMHC's review guidance.

One more thing: Kaiser's KPIC PPO, point-of-service and out-of-area plans use different drug lists. If your card says one of those, check that list instead. Kaiser formulary directory.

Northwest (Oregon and southwest Washington): find your lane first

Your lane decides which requirements apply. The heart and kidney lanes have different drug rules. The standard new-start lane has an A1c ceiling.

Kaiser Northwest runs Ozempic through its Criteria-Based Consultation Prescribing Program, which checks your chart against written rules. Here are the main branches in the injection criteria effective July 1, 2026. These are not Medicare criteria. Current injection document.

Source: Kaiser Northwest injection criteria, pages 1–4. The document also has separate already-taking branches for heart disease, kidney disease and ages 12–19. The heart and kidney branches retain their listed SGLT2/liraglutide restrictions; "already taking it" does not erase every drug requirement.

The kidney row is more specific than "some protein in my urine." Bring the actual urine ratios, dates and kidney-function result to your clinician. Do not self-diagnose from the table.

What does "0.5 units per kg per day" look like? A 200-pound person weighs about 91 kg. Half a unit per kg is about 45 units of insulin a day. That is an explanation of the policy's math, not a dose recommendation.

Kaiser's age range is not the FDA age range. Northwest includes ages 12–19 in this policy, but Ozempic's injection label is for adults and says pediatric safety and effectiveness have not been established. Use under age 18 would be off-label. An insurance rule does not change FDA approval. Ozempic prescribing information.

Watch the date on any Kaiser Northwest PDF you find. We found three versions of the injection criteria still online:

If you're preparing from an older file, you may be studying for the wrong test.

The Ozempic tablet has its own rule. Kaiser Northwest posts separate criteria for Ozempic tablets, also effective July 1, 2026. The standard adult lane starts at age 18 instead of 20, and the tablet document has no separate kidney or teen lane. Make sure your request names the right product. Tablet criteria.

How to ask: Kaiser Northwest's drug-list page says the most effective way to request an exception is a secure message to your doctor. Northwest directory.

Mid-Atlantic (Maryland, Virginia, Washington D.C.): the current semaglutide form, 6-month approvals, and your refill record

For Commercial, Exchange and FEHB plans, diabetes approvals come 6 months at a time. Use the Semaglutide Products form—not the Maryland Medicaid form or an older general GLP-1 form.

Kaiser Mid-Atlantic's current form was revised July 28, 2026 and took effect August 4, 2026. It lists Ozempic injection as preferred for diabetes. Ozempic tablets and Rybelsus are non-preferred semaglutide products. Current form; Kaiser's form directory.

For the diabetes starting criteria, it asks your doctor to show:

• Type 2 diabetes. Other indications have their own sections and preferred products; a diabetes approval is not a weight-loss approval.
• An A1c from the last 3 months. If it is 2 or more percentage points above the goal, the form asks for optimized insulin therapy or its stated intolerance exception.
• Trials of metformin, an SGLT2 drug and liraglutide, at maximum-tolerated doses, or the listed intolerance/contraindication exceptions. The adequate-trial definition includes at least 80% medication adherence for 3 months or more.
• No overlapping GLP-1 or DPP-4 treatment prohibited by the form.
• New members: if you started outside Kaiser and have not been reviewed, the continuation section says you must meet the starting criteria.

Semaglutide Products form, diabetes and continuation sections.

Approval length: 6 months to start, then 6-month renewals for diabetes. The renewal section still checks adherence and other requirements. In the branch without established/high-risk cardiovascular disease, response options include reaching your A1c goal, a fall of at least 1 percentage point from before GLP-1 treatment, or a fall of at least 0.5 percentage point since the previous review. One response number alone does not satisfy the whole renewal form. Continuation criteria.

These numbers are for your doctor's office: fax 1-844-785-2802, questions 1-866-331-2103. The form warns that incomplete forms slow things down. Its request to fax information back within 24 hours is not a promise of a 24-hour coverage decision. Current form.

Maryland Medicaid members: Kaiser publishes a different GLP-1 form for you. Its cover also shows an August 4, 2026 effective date, and its product preferences differ. Use the Maryland Medicaid form, not the Commercial/Exchange/FEHB version.

Washington (Kaiser Permanente Washington): approval with step rules, and a weight twist

In Kaiser Washington, Ozempic is the semaglutide Kaiser uses, even for members with a weight-loss rider.

Kaiser Washington's January 2026 provider notice says it covers Ozempic as its semaglutide product for select uses, including diabetes and members with weight-loss rider coverage. The same notice says Ozempic requires prior authorization, including step criteria. It also says the Wegovy pill isn't covered on Kaiser Washington commercial plans. Provider notice.

The Kaiser Washington formulary checked here shows Ozempic at Tier 2 with PA and a quantity limit. It also explains weight-loss benefit exclusions. So if you want Ozempic for weight, check the rider and its criteria, not just the diabetes drug listing. Washington formulary.

We did not find a full clinical checklist in the Washington sources we reviewed. Ask for it: "Can you send me the written criteria Kaiser uses for Ozempic on my plan?"

Georgia: public criteria, and a difference between preferred and no PA

Kaiser Georgia publishes detailed Ozempic criteria. Its standard non-Medicare diabetes branch starts with a 6-month approval and allows 12-month renewals when the continuation rules are met.

Kaiser Georgia's 573-page restricted-drug review document took effect September 9, 2026. Requests go to its Pharmacy Consult Service. In its diabetes GLP-1 section, Ozempic is preferred among products needing review; generic liraglutide is described as preferred without PA. Those are not the same status. Georgia review criteria, printed pages 204–206.

For the standard new-start diabetes branch, the review looks for type 2 diabetes, age 18 or older, a recent A1c within the stated distance of goal or insulin use, a metformin trial, and a liraglutide trial unless an allowed exception applies. The metformin trial includes 3 months at maximum-tolerated dosing and at least 80% refill-based adherence. The liraglutide step includes failure to reach the A1c goal or lower A1c by at least 0.8 percentage point after the stated 3-month trial, unless intolerance or a contraindication applies. Other branches cover qualifying heart or kidney disease and people who joined Kaiser already taking treatment. Georgia criteria.

The standard diabetes branch allows 6 months initially and 12 months on continuation. Some qualifying cardiovascular or kidney branches allow ongoing approval without that same fixed interval. Use the approval length on your own notice, not a single statewide number. Georgia criteria.

Georgia's drug lists put the starter-dose Ozempic pen on Tier 4 in the four-tier formulary and Tier 5 in the five-tier formulary, both with PA and quantity limits. Those tier numbers do not give your dollar copay. The five-tier formulary also prints restriction codes beside liraglutide, despite the review criteria describing the generic as preferred without PA. Have the pharmacy confirm the exact product and benefit before assuming no review is needed. Four-tier formulary; five-tier formulary; review criteria.

For weight management, the criteria name Wegovy as preferred. They also describe circumstances where someone already approved for or taking Ozempic may continue. Finding Ozempic in the weight-treatment section is not proof that a new weight-loss request will be approved. Georgia weight-management criteria, printed pages 202–204.

Colorado: approval plus a day-supply limit

Colorado's HMO and Marketplace formularies list PA for Ozempic. They do not supply a full Ozempic clinical checklist. Ask for the criteria tied to your plan.

Kaiser Colorado's HMO and Marketplace lists show Ozempic at Tier 3 with prior authorization and a day-supply limit (a cap on how many days one fill can cover). If an SGLT2 drug is part of your treatment, the Marketplace list places generic dapagliflozin on Tier 2 and Jardiance on Tier 3. Ask for the actual copay for each; a lower tier alone is not a personal price quote. Colorado HMO; Marketplace.

Hawaii: the listing does not settle the approval question

Hawaii's Marketplace formulary effective September 1, 2026 lists Ozempic at Tier 3. It does not show a PA code beside the listing. That is not enough to promise no approval is needed. Hawaii formulary.

Ask your care team or Member Services: "For my exact plan and Ozempic product, is any prescribing review or prior approval needed, and which document sets that rule?"

### Put my Kaiser request packet together → You have the regional rules. Now use the checklist and copyable message to ask your care team what is missing—without submitting personal medical details to this page.

---

Is there a Kaiser Ozempic prior authorization form, and what should my doctor send?

There is no single Kaiser Ozempic prior authorization form. Mid-Atlantic has plan-specific forms, Northwest links a general coverage-request form, and Medicare follows a separate Part D process. Match the form to your plan and request before gathering the records it asks for. Mid-Atlantic directory; Northwest directory; Medicare process.

Don't download another region's form. The rules behind it are different.

Your Kaiser Ozempic request checklist

Use this before sending a message or making a call. It is a preparation checklist, not an eligibility result.

1. Name your plan: region, exact plan name, and commercial, Marketplace, Medicare, Medicaid, FEHB or PSHB.
2. Name the medicine: Ozempic injection or tablet, plus the strength.
3. Name the problem: no prescription, no request sent, pending review, written denial, or pharmacy rejection.
4. Match the document: use the regional source above and its effective date. Already taking Ozempic? Check the existing-treatment branch.
5. Ask for one concrete next step: the missing record, the right request, or the written decision and appeal deadline.

Use the worksheet below for your records. Keep your member number, labs and medical records in your care team's secure system—not in a public comment or an affiliate-site form.

Your Kaiser Ozempic request packet

Kaiser Northwest's request form asks prescribers for the medicine and strength, the reason, whether it's new, every medicine tried with approximate dates and why it was stopped, and the prescriber's reasoning. We built this worksheet around those same fields, then added a tracking row so you have a record to follow up on. Northwest request form.

Form fields; product and clinical criteria.

Who can ask for a decision?

For a clinical PA form, the prescribing team supplies the medical information. But that does not mean members can never ask for review themselves: Kaiser also describes member-initiated exception and grievance processes. You help by making sure the facts are in your chart and asking which process applies. California; Northwest.

On Kaiser Medicare, you can ask for a coverage decision yourself. For an exception, though, Kaiser needs a supporting statement from your prescriber. Kaiser Medicare instructions.

Copy this message for your Kaiser doctor

"Hi Dr. [Name]. I'm asking about Ozempic for [the condition you are treating]. Can you tell me what's blocking it right now: a prescribing decision, a prior authorization, a formulary exception, or a pharmacy problem? My last A1c was [X]% on [date], if needed for this request. I currently take [medicines and doses]. I've also taken [medicine, dose, dates], and stopped because [what happened]. Which Kaiser Ozempic criteria apply to my plan, and is anything missing before we send the request?"

Use only facts that are true and documented. Delete any field that does not apply.

Your next step: Copy the message above, fill in the details you know, and send it through Kaiser's secure messaging. Ask your team to confirm the missing item before a request goes in.

---

How long does Kaiser prior authorization take for Ozempic?

We found no published Kaiser-wide average for Ozempic approvals. For Medicare Part D, an initial decision about a drug you have not received is generally due within 72 hours, or 24 hours for an expedited request. An exception has a different starting point. An appeal has a different deadline. CMS coverage determinations; CMS exceptions.

These are decision clocks, not promises about appointments, required medication trials, shipping or pharmacy stock. A request to repay you for medicine already bought can also use different deadlines. CMS.

Missing information can delay a request, but it is not a reason to assume every clock restarts or pauses. Ask exactly what is missing and which deadline the reviewer is using.

What counts as "urgent" for Medicare? Waiting under the standard process could seriously harm your health or ability to function. Being eager to start doesn't qualify. If Kaiser Medicare turns down a fast review, it uses the standard process. Medicare review instructions.

Heard nothing? Send this:

"Hi. I'm checking on my Ozempic request. Was it received, and on what date? Is it complete, or is Kaiser waiting on anything? Who is reviewing it? What's the decision deadline for this kind of request?"

Write down the answer, the date, and the name of the person who replied. If the deadline passes, contact the plan's coverage-review or appeal team with that record rather than starting an unrelated paid program just to chase the same request.

---

Why did Kaiser deny my Ozempic, and how do I fix it?

Get the exact reason in writing before you resend or appeal. The next step differs for an A1c requirement, missing drug history, the wrong policy branch, a benefit exclusion or a pharmacy rejection. Some problems are missing paperwork; others require a medical decision or a formal challenge. Kaiser review process; Northwest criteria.

Sending the same request again, unchanged, does not address the reason for denial. Use this decoder to find your next question.

The table maps published rules to questions. It does not tell you which reason applies without your notice and records.

Fix it, resend it, or appeal it?

• Fix and resend when the gap is paperwork, like a missing record. Ask whether the plan wants a corrected submission or an appeal; do not let resubmission make you miss an appeal deadline.
• Ask for an exception when the drug isn't normally covered for you, but your doctor can show you need it.
• Appeal when you disagree with the decision itself.

Where to appeal, by plan

Want help writing the letter? Use our free GLP-1 appeal letter template. Match the letter to the actual denial and attach the records it needs. The template does not replace your clinician's medical explanation.

### Get my personalized action plan → Denied, stuck, or comparing your options after checking coverage? The RX Index's Find My GLP-1 Path tool helps you compare providers and treatment paths based on your situation. Free. It's a starting point for your decision, not a Kaiser coverage ruling.

---

Can Kaiser approve Ozempic for weight loss?

Kaiser can cover Ozempic for weight loss on some plans, but a diabetes drug listing does not establish that benefit. Weight management is not an FDA-approved Ozempic injection use. Kaiser Washington explicitly names Ozempic for members with a weight-loss rider; the correct answer depends on the plan's benefit and criteria. Ozempic label; Washington notice.

We know that's not what you hoped to read. Stick with us, because there's a better question to ask, and a clear path if the answer is still no.

Two walls: the label and the benefit

Wall 1 is the label. The FDA approved Ozempic injection for uses in adults with type 2 diabetes: improving blood sugar control with diet and exercise; reducing major cardiovascular events in those who also have established cardiovascular disease; and reducing specified kidney and cardiovascular risks in those who also have chronic kidney disease. Weight management is not on that list. Prescribing Ozempic for weight loss is off-label, even when an insurer permits it. Ozempic prescribing information.

Wall 2 is the benefit. A doctor's letter can't create a benefit your plan never bought. But first confirm whether the plan really excludes the requested treatment, whether a rider applies, and whether the denial used the right reason for treatment. Kaiser's documents separate drug-list status from the benefits you bought. How Kaiser's formulary works.

Where Kaiser's rules get interesting

These are coverage-policy findings, not new FDA indications for Ozempic.

The one question to ask

Skip "Will Kaiser cover Ozempic for weight loss?" Ask this instead:

"Does my plan include a weight-loss drug benefit or rider? If it does, which semaglutide does it use, Ozempic or Wegovy, and what are the criteria?"

If you got Kaiser through work, ask HR the same thing. Say "weight-loss drugs, not diabetes drugs," or you may hear "yes, we cover GLP-1s" when they mean diabetes only.

If the answer is yes, start with your Kaiser care team and the current product-specific document linked above. Ask about both the covered medicine and its requirements before paying an outside program.

Please don't change your diagnosis to fit a rule. Ask your care team to correct missing or wrong records, not to list a condition you don't have.

Your plan has no weight benefit? Here is a separate FDA-approved self-pay path.

Ro membership does not buy you Kaiser coverage. It adds a care fee, and medication costs are separate. If getting Kaiser to pay is your top priority, your Kaiser care team is the better starting point. Check your regional rule before you pay for another program. Ro pricing; Ro insurance terms.

But paying cash for a prescribed medicine avoids an insurer's prior-authorization decision. That lets you compare an actual cash price when your plan has no applicable benefit. It does not skip the medical review, promise a prescription, or guarantee an immediate start. Ro offers clinician-guided care and FDA-approved medication options; the clinician decides whether treatment fits. Ro program.

What Ro publishes (checked September 22, 2026):

• Get started for $39, then as low as $74/month with annual plan paid upfront. Month to month, it's $149. The $74 is a monthly equivalent, not a monthly-payment option; check the total upfront charge before paying. Ro says the $39 is refunded if you are not eligible for GLP-1 treatment. Medication is billed separately. Ro pricing.
• Wegovy pen through Ro: the advertised new-patient offer is $199 per fill for the first two qualifying 0.25 or 0.5 mg fills. The manufacturer offer runs through December 31, 2026; it is not just a sign-up deadline. After the offer, 0.25–2.4 mg pens are $349 per month; the 7.2 mg HD product is $399. The Wegovy pill starts at $149 for the 1.5 mg strength, not every dose. Ro's dose-price table; manufacturer offer terms.
• Ro says its cash medication prices match NovoCare, LillyDirect and TrumpRx. That is Ro's published claim, not a guarantee that it gives every reader the lowest total cost after membership. Ro pricing.
• A licensed provider decides if a medicine like Wegovy, Zepbound or Foundayo is right for you. Ozempic is on Ro's menu too. Availability of a product does not make every use FDA-approved. Ro pricing and medicines.
• The membership renews on its own. Ro's terms say to cancel at least 48 hours before your renewal date to avoid the next charge. Ro terms.

What the provider says—and what we actually checked

A useful total, not just a teaser price: Ro's $149 monthly membership plus a $349 Wegovy fill is $498 for that month. That is our arithmetic using the published prices, not a personal quote or the annual-prepay rate. Membership; medication price.

### See Ro's program and eligibility steps → (sponsored) Get started for $39, then as low as $74/month with annual plan paid upfront. Medication is extra. This is a separate care option, not a Kaiser coverage workaround.

Skip Ro if Kaiser already covers the right medicine for you at a lower total cost.

Want to pick your own clinician? Sesame's weight program starts at $59 a month with an annual plan paid upfront, and medication is extra. Some clinicians charge more. See Sesame's current plans (sponsored) or read our Sesame review. Sesame's program terms.

---

I already take Ozempic and just joined Kaiser. Do I need a new approval?

A prior plan's approval does not settle the new plan's request. Northwest has separate already-taking branches, while Mid-Atlantic's Commercial, Exchange and FEHB form says new members who have not been reviewed must meet the starting criteria. Your records from before Kaiser matter. Northwest; Mid-Atlantic.

Here's how the two published rules compare:

Build your "already taking it" file:

• Your current dose and start date
• The diagnosis it was prescribed for
• Your A1c from before you started any GLP-1. This one is gold, and it's easy to lose.
• Your most recent A1c
• Pharmacy fill history from your old plan
• Any old approval letters
• Every diabetes medicine you've tried, with dates and why you stopped
• Any side-effect history

Planning tip—not a Kaiser deadline: About 30 days before your old coverage ends, download your labs and pharmacy records. Contact Kaiser early to arrange care when your new benefits begin; appointment timing and access before enrollment can vary. Don't wait until you're out.

Don't change your dose, skip doses, or let your blood sugar climb to fit a rule. Ask your Kaiser care team for a plan so you don't run out.

---

How does Ozempic prior authorization work on Kaiser Medicare, Medi-Cal, or a federal plan?

Use your program's rules, not the commercial criteria above. Kaiser Medicare lists PA for Ozempic; the separate $50 Medicare GLP-1 Bridge does not include Ozempic. Medi-Cal Rx handles Kaiser Medi-Cal outpatient pharmacy coverage. Federal and postal employees need their exact plan documents. Kaiser Medicare; Medicare Bridge; Medi-Cal Rx.

Kaiser Medicare (Senior Advantage)

• The October 1 list. The published formulary effective October 1, 2026 lists Ozempic pens at Tier 3 with PA. As of this September 22 check, that is a future-dated list—not proof of a newly added October 1 requirement. Ask: "Is a PA required for my current prescription, and does my existing approval remain valid?" Formulary.
• Do not import commercial steps. The California Part D criteria for the listed diabetes drugs cover FDA-approved uses not excluded from Part D. They list no Northwest-style A1c or prior-drug checklist and state coverage through the end of the plan contract year. Use the criteria for your Medicare plan. California Part D PA document.
• How to ask for a decision. You, your representative or your prescriber can ask. Kaiser's Northern California Medicare page lists OptumRx's prior authorization department: 1-877-645-1282 (TTY 711), 8 a.m. to 8 p.m., 7 days a week; fax 1-844-403-1028. Use your own region's Medicare page or member card to confirm the contact. Kaiser instructions.
• The clocks. For an initial benefit request, standard decisions are due within 72 hours and expedited decisions within 24 hours of receipt. For an exception, the clock starts with the prescriber's supporting statement. CMS determinations; exceptions.
• If you're denied. You generally have 65 days from the date on the denial notice to request the first appeal. Standard benefit appeals take up to 7 days; expedited appeals up to 72 hours. Medicare appeals.
• The $50 Bridge is not for Ozempic. It covers Foundayo tablets, Wegovy injection or tablets, and Zepbound KwikPen for eligible adults with Part D, at $50 for a 28- or 30-day supply. It requires its own medical criteria and PA; having Medicare alone is not enough. Type 2 diabetes belongs in the regular Part D coverage process instead. Medicare eligibility and drug list; our Kaiser Bridge guide.
• The Bridge has a separate cost rule. Its $50 copay does not count toward the Part D deductible or annual out-of-pocket limit. Extra Help does not reduce that Bridge copay. Medicare.
• The Ozempic commercial savings card does not work with Medicare. Do not confuse that card with a separate self-pay offer that has its own eligibility terms. Ozempic savings terms.

Medi-Cal through Kaiser

Medi-Cal Rx, the state's pharmacy program, runs outpatient drug coverage for Medi-Cal members, including Kaiser Medi-Cal members. Medi-Cal Rx.

• Ozempic remains listed for type 2 diabetes, subject to the diagnosis restriction and other claim rules. If the pharmacy gets Reject 80, the claim did not meet the diagnosis restriction. Your prescriber and pharmacy should check the correct, documented diagnosis and claim details. This does not mean every rejection needs a new PA. January 2026 update.
• The January 1, 2026 change removed routine adult GLP-1 coverage for weight loss; it did not remove Ozempic coverage for type 2 diabetes. Members under 21 can have medically necessary weight-loss treatment reviewed through the pediatric benefit process. For an existing approval, ask Medi-Cal Rx to check the authorization and any continuation rules rather than assuming a general weight-loss notice cancels it. Medi-Cal Rx member guidance.
• If you get a denial notice, you generally have 90 days to ask for a State Hearing. Medi-Cal Rx also describes a narrower continuation rule for people already taking a GLP-1 on or before January 1, 2026: requesting a hearing within 10 days of receiving the notice may continue coverage while the hearing is pending, subject to the stated limits. It is not a blanket 10-day rule for every new request. Follow the dates and instructions on your notice. Hearing and continuation guidance.

For a claim-specific answer, call Medi-Cal Rx at 1-800-977-2273, available 24 hours a day, 7 days a week. Have the rejection or denial notice ready. Medi-Cal Rx member guidance.

Federal and postal employees (FEHB and PSHB)

Your 2026 plan brochure controls. Search it for "Ozempic," "semaglutide," "prior authorization," and "weight loss." Don't borrow another plan's rules. Mid-Atlantic's current semaglutide form explicitly includes FEHB; that does not make it the rule for every federal or postal Kaiser plan. Mid-Atlantic form.

---

Should I wait for Kaiser or pay cash for Ozempic?

Check your Kaiser-covered price before adding a cash-pay program, but do not delay needed care while you wait for paperwork. Compare the actual covered cost with the full cash price, including any separate care fee. Novo Nordisk's Ozempic pen offer starts at $199 for two qualifying introductory fills, then $349 to $499 by dose. Ozempic prices and terms.

Go in this order:

1. Kaiser coverage for the documented reason. Use the packet and message above. Ask for the approved dose, your actual pharmacy price, and a care plan while the request is being reviewed.
2. Medicare members: regular Part D for type 2 diabetes. The $50 Bridge covers eligible weight-management patients using its listed products—not Ozempic. Medicare Bridge.
3. Novo Nordisk's self-pay prices (checked September 22, 2026): compare the dose you are prescribed, not just the starting price. A valid prescription and offer eligibility are required. Official prices.
4. A telehealth program like Ro or Sesame, if you want a separate prescriber and ongoing support, and you understand the membership is on top of the medicine. Ro; Sesame.

Source: Novo Nordisk's Ozempic savings and self-pay terms, checked September 22, 2026. These are the listed offers, not a quote from every pharmacy. Follow the prescribed dose; do not choose a dose just for its price.

The direct Kaiser, Medicare and manufacturer links above are not affiliate links. They may let you use existing care without another membership fee. For the broader cost question, including the Ozempic savings card, see Does Kaiser cover Ozempic?.

---

Kaiser Ozempic claims online vs. what Kaiser's documents say

A claim about "Kaiser" can be wrong simply because it uses another plan's rule. Here is how to check broad claims against the documents that actually apply.

---

How we built this page

We checked Kaiser's published criteria, forms, drug lists and notices, and recorded the plan scope and document dates. We then compared the requirements with the request, denial and cost questions readers need to resolve. Where the reviewed sources did not establish a fact, we did not fill the gap with an approval guess.

The RX Index: independent guidance for choosing your GLP-1 path. Here's exactly how we made this page:

• What we opened: every document in the "What we actually verified" box at the top, plus Medicare's Bridge rules and Medi-Cal Rx notices. All checked September 22, 2026.
• How we compared them: we located the Ozempic and semaglutide entries and relevant criteria sections, checked document text and available page images, and recorded plan scope, product, starting versus ongoing treatment, drug trials, A1c rules, approval length and effective dates.
• How we handled old versions: we followed Kaiser's current directory to the linked rule, recorded its date, and labeled older copies as older, even when they still download.
• What we won't publish: unsupported approval rates, a national Kaiser copay, or one region's rule dressed up as national.
• Testimonials: we don't post patient stories on insurance pages. Someone else's approval can't tell you what your plan requires.
• Review: no clinician reviewed this page, and we won't pretend one did. This is insurance research, not medical advice. See our methodology and corrections policy.

Verification record: Sources checked September 22, 2026. The document-version table above distinguishes older policies from current directory-linked criteria. Provider prices are advertised prices, not personally tested checkout results.

---

Frequently asked questions

Does Kaiser require prior authorization for Ozempic?

It depends on the exact plan. California's commercial HMO and Marketplace formularies say no plan-level PA is required. Other Kaiser plans publish approval requirements or criteria. Medicare has a separate process. California; Medicare.

What A1c do I need for Kaiser to approve Ozempic?

In Northwest's standard adult new-start branch, A1c or GMI must be above 6.9% and below 10% after the required medicine trial. Mid-Atlantic's Commercial, Exchange and FEHB form compares a recent A1c with your personal goal and requires optimized insulin or its stated exception when it is 2+ points above goal. Neither is a national Kaiser rule. Northwest; Mid-Atlantic.

Do I have to try metformin before Ozempic at Kaiser?

Several published non-Medicare branches require metformin or a qualifying intolerance/contraindication exception. Northwest's standard adult new-start branch uses 2 of 4 oral medicines plus liraglutide requirements, not metformin alone. Mid-Atlantic's current diabetes form includes metformin, an SGLT2 drug and liraglutide. Northwest; Mid-Atlantic.

What is liraglutide, and why does Kaiser want it first?

Liraglutide is an older, once-a-day GLP-1 shot, sold as Victoza and as a generic. Kaiser lists it as a preferred or required earlier treatment in several non-Medicare criteria. The exact branch determines whether a trial or a documented intolerance/contraindication is needed. FDA; Northwest; Georgia.

How long does Kaiser take to approve Ozempic?

We found no Kaiser-wide average. A Medicare Part D initial benefit decision is generally due within 72 hours, or 24 hours when expedited. For an exception, those clocks start with the prescriber's supporting statement. Non-Medicare requests need the deadline for their own plan and request type. CMS determinations; exceptions.

Can Kaiser approve Ozempic for weight loss?

Some plans can. Kaiser Washington explicitly names Ozempic for members with a weight-loss rider, subject to PA and step criteria. Ozempic injection is not FDA-approved for weight management, and a diabetes formulary listing alone does not create a weight-loss benefit. Washington notice; Ozempic label.

Can my outside or telehealth doctor send the Kaiser prior authorization?

Do not assume an outside prescription qualifies for your Kaiser benefit. Kaiser plans can have prescriber and pharmacy network requirements, with exceptions. But an outside prescriber is not universally barred from requesting review: Kaiser's Medicare process permits a member or prescriber to ask for a decision. Confirm both the request process and whether the resulting prescription can be covered. Kaiser Medicare instructions; California plan types.

Is there one Kaiser Ozempic prior authorization form?

No. Mid-Atlantic uses a Semaglutide Products form for Commercial, Exchange and FEHB plans, plus a separate Maryland Medicaid form. Northwest links a general drug coverage-request form. Medicare uses a Part D coverage-decision process. Mid-Atlantic directory; Northwest; Medicare.

What if my A1c is over 10%?

That does not meet Northwest's standard adult new-start branch, which requires A1c below 10%. Its higher-insulin new-start branch has no upper A1c limit, but it has its own treatment requirements. Ask your clinician which branch applies; do not change your insulin dose to meet a coverage rule. Northwest criteria.

Does a high coronary calcium score count as heart disease for Kaiser's rule?

Not by itself in Northwest's qualifying heart/artery-disease branch. Its definition includes specified events and diagnoses such as heart attack, angina, revascularization, atherosclerotic stroke/TIA or symptomatic peripheral artery disease. Risk factors or a calcium score alone do not qualify for that branch. Northwest criteria.

I started Ozempic before joining Kaiser. Do I start over?

It depends on the plan. Northwest has already-taking branches; the adult lower-insulin branch has an A1c below 10% requirement and no listed liraglutide step, while its higher-insulin alternative differs. Mid-Atlantic's Commercial, Exchange and FEHB form requires new members who have not been reviewed to meet the starting criteria. Bring your old treatment records. Northwest; Mid-Atlantic.

How long does a Kaiser Ozempic approval last?

Mid-Atlantic's cited diabetes form uses 6-month initial approvals and renewals. Georgia's standard diabetes branch uses 6 months initially and 12 months on continuation, while other branches differ. Northwest's current injection criteria do not state a duration. California's cited Medicare criteria state coverage through the end of the plan contract year. Your approval notice gives your own end date. Mid-Atlantic; Georgia; Northwest; Medicare.

Does Kaiser Medicare need prior authorization for Ozempic?

The published Kaiser Medicare formulary effective October 1, 2026 lists Ozempic pens at Tier 3 with PA. It does not establish that the requirement first begins that day. Ask whether PA applies to your current prescription and whether an existing authorization remains valid. Kaiser Medicare documents.

Can I ask Kaiser for a decision myself?

On Medicare, yes: you or your representative can ask for a coverage decision. An exception still needs your prescriber's supporting statement. Kaiser also describes member-initiated exception or grievance processes for non-Medicare plans; clinical forms need information from the prescribing team. Medicare; California; Northwest.

Does the Ozempic pill follow the same Kaiser rules as the shot?

Not exactly. Northwest publishes separate tablet criteria. The tablet's standard adult branch starts at 18, versus 20 in the injection criteria, and the tablet document has no separate kidney or teen branch. Mid-Atlantic's current form also distinguishes preferred Ozempic injection from non-preferred oral products. Northwest tablet criteria; Mid-Atlantic form.

Will Kaiser cover compounded semaglutide instead?

We did not find a compounded semaglutide coverage listing in the Kaiser documents reviewed. That is not a decision about every possible plan benefit. Compounded medicines are not FDA-approved and are not Ozempic. Ask your plan about the actual product before treating it as a covered substitute. FDA compounding guidance.

---

Still not sure which GLP-1 program is right for you? Use our free Find My GLP-1 Path matching tool.

---

Related Kaiser guides

Does Kaiser Cover Ozempic? · What GLP-1 Does Kaiser Cover? · Kaiser Mounjaro Prior Authorization · GLP-1 Providers That Accept Kaiser · Kaiser and the $50 Medicare Bridge · GLP-1 Appeal Letter Template

Sources

Kaiser Permanente policy and plan documents

• Northwest: current Ozempic injection criteria, effective July 1, 2026; separate tablet criteria, effective July 1, 2026.
• Northwest: older criteria effective June 4, 2026; older criteria effective November 6, 2025; current formulary directory; drug coverage-request form.
• Mid-Atlantic: Semaglutide Products form for Commercial, Exchange and FEHB, effective August 4, 2026; separate Maryland Medicaid GLP-1 form; current form directory.
• Georgia: restricted-drug review criteria, effective September 9, 2026; four-tier formulary; five-tier formulary.
• Washington: January 2026 provider notice; Washington formulary.
• Northern California commercial HMO formulary; Southern California commercial HMO formulary; California Marketplace formulary; California formulary and exception instructions.
• Colorado HMO formulary; Colorado Marketplace formulary; Hawaii Marketplace formulary.
• Kaiser Medicare 2026 instructions; published October 1, 2026 formulary; California Medicare prior-authorization criteria.
• Kaiser: how the formulary works.

Government, clinical-label and member-rights sources

• Ozempic injection prescribing information, revised May 2026.
• CMS: Part D coverage determinations; CMS: exceptions; Medicare: Part D appeals.
• Medicare: GLP-1 Bridge covered drugs, eligibility and costs.
• Medi-Cal Rx: January 2026 provider update; member coverage and State Hearing guidance.
• California DMHC: complaint and Independent Medical Review guidance.
• NIDDK: the A1c test; FDA: generic liraglutide approval; FDA: compounding questions and answers.

Prices and program terms—checked September 22, 2026

• Novo Nordisk: Ozempic savings and self-pay terms; NovoCare: Wegovy savings-offer terms.
• Ro pricing; Ro's Wegovy dose-price table; Ro insurance information; Ro membership terms.
• Success by Sesame: program pricing and terms.

This page is independent insurance research, not medical advice or a coverage guarantee. Coverage decisions belong to your plan. Treatment decisions belong to you and your clinician. Ozempic® and Wegovy® are trademarks of Novo Nordisk. The RX Index is not affiliated with Kaiser Permanente, Novo Nordisk, Medicare or Medi-Cal. Commercial links to Ro and Sesame are disclosed as affiliate links.